WallStSmart
CING

Cingulate Inc

NASDAQ: CING · HEALTHCARE · BIOTECHNOLOGY

$4.71
+0.64% today

Updated 2026-04-29

Market cap
$67.01M
P/E ratio
P/S ratio
EPS (TTM)
$-4.44
Dividend yield
52W range
$3 – $12
Volume
0.5M

WallStSmart proprietary scores

16
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
5.0
Quality
C+
3.0
Profitability
D
5.0
Valuation
C+
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target
$28.70
+509.34%
12-Month target
Intrinsic (DCF)
Margin of safety
1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-9.52M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$-17.85M$-23.53M$-15.55M$-22.45M$-6.52M
EPS$-4.44
Free cash flow$-16.04M$-15.26M$-18.66M$-17.41M$-9.52M
Profit margin

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
CING$67.01M164.33.05.05.0Avoid
LLY$789.69B7810.010.05.06.5Strong Buy
JNJ$547.64B594.79.03.36.0-41.97%Buy
ABBV$351.47B634.08.04.75.0-24.92%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

Cingulate Inc trades at $4.71. Our Smart Value Score of 16/100 indicates the stock is weak.

Frequently asked questions

What is Cingulate Inc's stock price?
Cingulate Inc (CING) trades at $4.71.
Is Cingulate Inc overvalued?
Smart Value Score 16/100 (Grade F, Strong Sell).
What is the price target of Cingulate Inc (CING)?
The analyst target price is $28.70, representing +509.3% upside from the current price of $4.71.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio
ROE-450.60%
Beta-0.77
50D MA$6.58
200D MA$4.92
Shares out0.01B
Float0.01B
Short ratio
Avg volume0.5M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years